Representative before the EPO

Employment test 1 - 10 employees
Company dna avidity ip ltd
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

William Gwyn Cole has worked on the following 112 EPO patent applications which have been published in the last five years:

EP11768642

METHODS AND COMPOSITIONS FOR INTRANASAL DELIVERY

IPC classification:
A61K 9/19, A61K 35/74, A61K 35/76, A61K 39/00, A61K 39/05, A61K 39/08, A61K 39/145, A61K 47/26, A61K 47/38, A61P 31/04, A61P 31/12, A61P 31/16
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP12180542

Methods, compositions, and formulations for preventing or reducing adverse effects in a patient

IPC classification:
A61K 31/70, A61K 31/7056, A61K 31/7076
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814141

COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS

IPC classification:
A61K 31/195
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12814940

NOVEL COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER

IPC classification:
A61K 31/58
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12827951

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A01N 35/00, A61K 31/12
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12831538

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/498, C07D 241/36
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13189492

Alpha- and gamma-MSH analogues

IPC classification:
C07K 14/685
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Høiberg A/S
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12842391

PEPTIDOMIMETIC MACROCYLES

IPC classification:
A61K 38/12, A61K 38/16, C07K 14/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13189570

Method for generating dry vaccine powder formulation for intranasal delivery

IPC classification:
A61K 9/19, A61K 35/74, A61K 35/76, A61K 39/00, A61K 39/05, A61K 39/08, A61K 39/145, A61K 47/26, A61K 47/38, A61P 31/04, A61P 31/12, A61P 31/16
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12787341

MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS

IPC classification:
A61P 35/00, C07D 249/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12849310

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/4412
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12850561

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/4412
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13163392

A totally-enclosed device for quick detection of target nucleic acid amplification product

IPC classification:
B01L 3/00, C12Q 1/68, G01N 33/53
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
PATENT GRANTED
EP12806720

CHEMICAL COMPOUND USEFUL AS INTERMEDIATE FOR PREPARING A CATECHOL-O-METHYLTRANSFERASE INHIBITOR

IPC classification:
A61K 31/4425, A61K 31/4439, A61P 25/16, C07D 413/04
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12859516

METHODS AND COMPOSITIONS FOR COMBINATION THERAPY USING P13K/MTOR INHIBITORS

IPC classification:
A61K 31/56
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12779347

COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACITIVATION

IPC classification:
A61K 39/395, C07K 16/40, C12N 1/19, C12N 5/10, C12N 15/13, C12N 15/63, C12P 21/08
Applicant:
Omeros Corporation
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP14166121

Human protein tyrosine phosphatase inhibitors and their pharmaceutical use

IPC classification:
A61K 31/425, A61P 7/10, A61P 35/00, C07D 277/28, C07D 417/04, C07D 417/12, C07D 417/14
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Hoefer & Partner
Status:
GRANT OF PATENT INTENDED
EP12840725

TREATMENT OF OCULAR DISEASE

IPC classification:
A61K 39/395
Agent:
Louise Caroline Holliday, D Young & Co LLP
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12840220

METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER

IPC classification:
A61K 39/395
Agent:
Louise Caroline Holliday, D Young & Co LLP
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14181197

Minimally invasive devices for the treatment of prostate diseases

IPC classification:
A61B 18/04, A61B 18/18
Agent:
Jane Anne Clark, Mathys & Squire LLP
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14177981

Analgesic compositions comprising an antihistamine

IPC classification:
A01N 27/00, A01N 43/04, A61K 31/015, A61K 31/485, A61K 31/5415, A61K 45/06
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12789268

HYPERTENSION AND HYPERURICEMIA

IPC classification:
A01N 37/44, A61P 3/00, C07D 249/12, C07D 285/24
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
HGF Limited
Status:
PATENT GRANTED
EP12819309

STABLE ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/137, A61K 31/192, A61K 31/4174, A61K 47/10
Applicant:
Omeros Corporation
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP13754453

AUTOMATED IMAGE-GUIDED TISSUE RESECTION AND TREATMENT

IPC classification:
A61B 1/307, A61B 18/00, A61M 25/10
Agent:
Jane Anne Clark, Mathys & Squire LLP
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13755319

COMPOSITIONS AND KITS FOR MOLECULAR COUNTING

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13748983

PEPTIDOMIMETIC MACROCYCLES

IPC classification:
A61K 38/12
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14188300

Androgen receptor modulators and uses thereof

IPC classification:
A61K 31/4439, A61K 31/5025, A61P 5/26, A61P 5/28, A61P 35/00, C07D 401/04, C07D 471/04, C07D 487/04
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
PATENT GRANTED
EP13761578

COMPOSITION AND METHOD FOR DIVERSIFICATION OF TARGET SEQUENCES

IPC classification:
C12N 15/13, C12N 15/63, C12N 15/70, C12N 15/79
Applicant:
University of Washington CoMotion
Applicant:
Omeros Corporation
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13757679

PORTABLE DEVICE FOR DETECTING MOLECULE(S)

IPC classification:
B01L 7/00, G01N 21/00, G01N 27/10, H01L 35/00, H05B 1/00, H05B 3/00
Applicant:
Otago Innovation Limited
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13761026

ENZYMATIC REMOVAL OF STERYL GLYCOSIDES

IPC classification:
C12N 9/24, C12P 19/16, C12P 19/20
Applicant:
Keclon SA
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13751112

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

IPC classification:
A61K 38/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12838242

SYSTEMS AND METHODS FOR MULTI-ANALYSIS

IPC classification:
A61B 6/00, C12M 1/00, G01N 35/00
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13161756

Reducing optical interference in a fluidic device

IPC classification:
B01L 3/00, C12M 1/34, G01N 33/542, G01N 33/543
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13749501

TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES

IPC classification:
A61K 38/12
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13758140

COMPOSITIONS, METHODS, AND KITS FOR REGULATING ENERGY METABOLISM

IPC classification:
A61K 38/54
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12742394

AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF

IPC classification:
A61K 9/00, A61K 31/4418, A61M 15/00, A61P 11/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP13781743

METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEINS

IPC classification:
G01N 33/58, G01N 33/68
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12833985

CERTAIN CHEMICAL ENTITES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/498, A61P 35/00, C07D 241/42
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13787493

METHODS AND APPARATUS FOR STIMULATING STRETCH RECEPTORS IN THE VASCULATURE

IPC classification:
A61B 17/12, A61B 17/122
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14193060

Methods for increasing the stabilization of hypoxia inducible factor-1 alpha

IPC classification:
A61K 31/497
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Gabriele Leissler-Gerstl, Hoefer & Partner
Status:
GRANT OF PATENT INTENDED
EP14179877

Novel compounds and compositions and methods of use

IPC classification:
A61K 31/4196, A61P 9/10, A61P 19/02, C07D 249/08, C07D 249/10, C07D 249/12, C07D 405/12
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP13726015

CLAMP FOR FAST PCR HEATING

IPC classification:
B01L 3/00, B01L 7/00, B01L 9/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13806568

STABILIZED DROPLETS FOR CALIBRATION AND TESTING

IPC classification:
C12M 1/38, C12Q 1/00, C12Q 1/68, G01N 33/48
Applicant:
Bio-rad Laboratories, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP11796324

TREATMENT OF GOUT AND HYPERURICEMIA

IPC classification:
A61K 31/4196, A61K 31/426, A61K 31/519, A61K 45/06, A61P 19/06, C07D 249/14
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
HGF Limited
Status:
GRANT OF PATENT INTENDED
EP11801499

ANTI-FIBROBLASTIC FLUOROCHEMICAL EMULSION THERAPIES

IPC classification:
A61K 9/12, A61K 31/02, A61K 31/03, A61P 35/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13820681

HIGH SPEED, COMPACT CENTRIFUGE FOR USE WITH SMALL SAMPLE VOLUMES

IPC classification:
B04B 9/00, B04B 13/00
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13820659

RAPID MEASUREMENT OF FORMED BLOOD COMPONENT SEDIMENTATION RATE FROM SMALL SAMPLE VOLUMES

IPC classification:
B01D 21/32, B04B 5/10, G01N 15/04, G01N 33/49, G06K 9/78
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13834985

METHODS FOR DISCOVERING THERAPEUTIC TARGETS

IPC classification:
C40B 30/04
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13834412

SYSTEMS, DEVICES, AND METHODS FOR BODILY FLUID SAMPLE COLLECTION

IPC classification:
A61J 1/05
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
The patent has been granted
EP13836969

INFORMATION MANAGEMENT SYSTEMS AND METHODS USING A BIOLOGICAL SIGNATURE

IPC classification:
C12Q 1/68
Applicant:
Theranos, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13842936

BIOCERAMIC COMPOSITIONS

IPC classification:
A61L 2/00, A61L 101/02, B29B 11/16, C04B 35/16, C08K 3/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13841597

SYSTEMS AND METHODS FOR RESPONSE CALIBRATION

IPC classification:
A61B 5/00, G06F 3/0484, G06Q 50/00
Applicant:
Theranos, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13843665

PHOSPHODIESTERASE INHIBITORS FOR TREATING TASTE AND SMELL DISORDERS

IPC classification:
A61K 31/352, A61K 31/401, A61K 31/416, A61K 31/4375, A61K 31/44, A61K 31/444, A61K 31/4704, A61K 31/472, A61K 31/473, A61K 31/4985, A61K 31/506, A61K 31/519, A61K 31/52, A61K 31/522, A61P 27/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13848501

DRUG MONITORING AND REGULATION SYSTEMS AND METHODS

IPC classification:
A61B 5/145, A61J 7/04, G01N 33/15, G01N 33/49
Applicant:
Theranos, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13848382

STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION

IPC classification:
A01N 43/48, A61K 31/40
Applicant:
Omeros Corporation
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13848352

ASSISTED MEDICAL AND ASSOCIATED LIFESTYLE DECISION MAKING

IPC classification:
G06Q 50/22
Applicant:
Theranos, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12742112

INTRANASAL DELIVERY DEVICES

IPC classification:
A61M 11/02, A61M 13/00, A61M 15/00, A61M 15/08, A61M 16/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13851076

DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 31/198
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13851971

COMBINATION THERAPIES

IPC classification:
A61K 31/16, C07H 19/12
Applicant:
MEI Pharma, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13857269

IMPROVED PEPTIDE PHARMACEUTICALS

IPC classification:
A61K 38/08, C07K 7/06, C07K 19/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13856357

IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

IPC classification:
A61K 38/16, A61P 3/10, C07K 19/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13858016

METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124

IPC classification:
C12N 5/071
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13863036

RAPID, LOW-SAMPLE-VOLUME CHOLESTEROL AND TRIGLYCERIDE ASSAYS

IPC classification:
C12Q 1/28, C12Q 1/44, C12Q 1/60, C12Q 1/61, G01N 33/49, G01N 33/52
Applicant:
Theranos, Inc.
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP15157262

Alpha- and gamma- MSH analogues

IPC classification:
C07K 14/685
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Høiberg A/S
Status:
GRANT OF PATENT INTENDED
EP15154363

Prolyl hydroxylase inhibitors

IPC classification:
A61K 31/497, A61P 31/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP15154235

Stabilized p53 peptides and uses thereof

IPC classification:
C07K 7/54, C07K 14/47
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
President and Fellows of Harvard College
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP15164257

COMPOSITIONS AND METHODS FOR TREATING COLITIS

IPC classification:
A61K 31/497, A61P 37/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14751655

SYSTEMS AND METHODS FOR COLLECTING AND TRANSMITTING ASSAY RESULTS

IPC classification:
G01N 1/28, G01N 33/48, G01N 35/00, G06F 19/10
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14751559

SYSTEMS AND METHODS FOR MULTI-ANALYSIS

IPC classification:
G01N 1/10, G01N 21/00, G01N 35/10
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14760298

REACTION VESSEL HOLDER AND MOLECULE DETECTION DEVICE

IPC classification:
B01L 7/00, G01N 21/00, H05B 1/00
Applicant:
Otago Innovation Limited
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14756899

COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF GRAFTS

IPC classification:
A61K 35/28, A61P 37/06
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14779612

SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS

IPC classification:
C07C 215/30
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14768511

ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF

IPC classification:
A61K 31/58
Applicant:
University of Maryland Eastern Shore
Applicant:
Thomas Jefferson University
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14768967

DEVICES, SYSTEMS AND METHODS FOR SAMPLE PREPARATION

IPC classification:
G01N 1/28, G01N 29/02, G01N 33/48
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14763454

SYSTEMS, DEVICES, AND METHODS FOR BODILY FLUID SAMPLE COLLECTION

IPC classification:
A61J 1/05, G01N 1/00
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14775078

METHODS, DEVICES, AND SYSTEMS FOR SAMPLE ANALYSIS

IPC classification:
C12M 3/00, G01N 33/48, G06M 11/02
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP15175346

IMMUNOLOGICAL COMPOSITIONS FOR HIV

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/21, C07K 14/005, C07K 14/035, C07K 19/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP14754263

METHODS, COMPOSITIONS, AND KITS FOR NUCLEIC ACID ANALYSIS

IPC classification:
C12Q 1/68, C40B 40/04, C40B 40/06, C40B 40/08
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP15172858

METHODS FOR DETERMINING CANCER RESISTANCE TO HISTONE DEACETYLASE INHIBITORS

IPC classification:
G01N 33/574
Applicant:
Pharmacyclics Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15170739

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/519, A61K 31/52, A61P 29/00, A61P 35/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP15171539

STABALIZED MAML PEPTIDES AND USES THEREOF

IPC classification:
A61K 38/00
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
President and Fellows of Harvard College
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12172843

Identification of bruton's tyrosine kinase inhibitors

IPC classification:
G01N 33/68
Applicant:
Pharmacyclics Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12166306

Inhibitors of Bruton's tyrosine kinase

IPC classification:
A01N 43/90, A61K 31/00, A61K 31/519, A61K 45/06, A61P 1/04, A61P 19/02, A61P 25/28, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP13153757

Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy

IPC classification:
A61K 31/164, A61K 31/343, A61K 31/40, A61K 31/4525, A61K 45/06, A61P 35/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14737648

NON-SELECTIVE KINASE INHIBITORS

IPC classification:
A61K 31/136
Applicant:
Gilead Sciences Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Andrew Philip Hartley, Mathisen & Macara LLP
Status:
EXAMINATION IN PROGRESS
EP12166295

Inhibitors of bruton's tyrosine kinase

IPC classification:
A61K 31/519, A61P 29/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15188218

NOVEL PRODRUGS OF STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS

IPC classification:
A61K 31/58, A61P 35/00, C07J 43/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14836226

BIOMARKERS FOR TREATMENT OF NEOPLASTIC DISORDERS USING ANDROGEN-TARGETED THERAPIES

IPC classification:
A61K 31/58, C07J 43/00
Applicant:
University of Maryland Baltimore
Applicant:
The University of Washington
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12166302

Inhibitors of bruton's tyrosine kinase

IPC classification:
A01N 43/90, A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP10742237

COMPOSITIONS COMPRISING OLEUROPEINS AND FLAVANOIDS AND THEIR USE

IPC classification:
A01N 43/16, A01N 65/00, A01N 65/08, A01N 65/36, A01P 1/00, A61K 8/49, A61K 8/60, A61K 31/353
Agent:
Dominic Stephen Elsworth, Hargreaves Elsworth
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13166272

Inhibitors of Bruton's Tyrosine Kinase

IPC classification:
A61K 31/519, A61P 19/02, A61P 19/10, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Jonquil Claire Irvine, Harrison Goddard Foote LLP
Agent:
Jonquil Claire Irvine, HGF Limited
Status:
PATENT GRANTED
EP15196132

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

IPC classification:
A61K 31/00, A61K 38/02, A61K 39/395, A61P 9/00, A61P 21/00, A61P 37/00
Applicant:
University of Leicester
Applicant:
Omeros Corporation
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP12703657

SYSTEM AND METHOD FOR PERSONALIZED INJECTION TREATMENT

IPC classification:
A61J 1/20, A61J 3/00, B01F 13/10, B01F 15/00, B01F 15/02, B05B 15/02
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
PATENT GRANTED
EP12172841

NITROGEN-CONTAINING CONDENSED HETEROCYCLIC AS INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/519, A61K 31/52, A61P 29/00, A61P 35/00, C07D 253/06, C07D 471/04, C07D 473/34, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13178059

Modular point-of-care devices and uses thereof

IPC classification:
A61B 5/15, G01N 1/38, G01N 33/543
Applicant:
Theranos, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP11769710

POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS

IPC classification:
A61K 31/137, A61K 45/06, A61P 35/00, A61P 35/02, G01N 33/574
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
PATENT GRANTED
EP12172840

Pyrrolo-pyrimidine analogues as inhibitors of bruton's tyrosine kinase

IPC classification:
A61K 31/519, A61K 31/52, A61P 29/00, A61P 35/00, C07D 253/06, C07D 471/04, C07D 473/34, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11703001

BACTERIAL DEOXYRIBONUCLEASE COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION

IPC classification:
A61K 38/46, A61L 29/16, A61P 1/02, A61P 17/02, A61P 31/04, A61P 43/00, C12N 9/22
Applicant:
Newcastle University
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
The patent has been granted
EP16164436

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

IPC classification:
A01K 67/027, A61K 39/395, C07K 14/47, C07K 16/40
Applicant:
University of Leicester
Applicant:
Omeros Corporation
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP12166296

Inhibitors of bruton's tyrosine kinase

IPC classification:
A01N 43/90, A61K 31/00, A61K 31/519, A61K 45/06, A61P 1/04, A61P 19/02, A61P 25/28, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13165749

Prolyl hydroxylase inhibitors

IPC classification:
A61K 31/497, A61P 35/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Hoefer & Partner
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16159660

GABA CONJUGATES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/191, A61K 31/675, A61P 25/00, C07C 229/00
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP12166298

Inhibitors of bruton's tyrosine kinase

IPC classification:
A01N 43/90, A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP12181773

LIQUID FORMULATION COMPRISING AN ALPHA-2 RECEPTOR AGONIST (E.G. CLONIDIN) AND OXYBUTYNIN (ANTI-MUSCARINIC AGENT) FOR THE TREATMENT OF SIALORRHOEA

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/216, A61K 31/415, A61K 45/06, A61P 43/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP12159110

Stitched polypeptides

IPC classification:
C07K 1/107, C07K 1/113, C07K 7/56, C12N 9/22
Applicant:
President and Fellows of Harvard College
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
PATENT GRANTED
EP10833991

METHODS AND COMPOSITIONS FOR DETECTING GENETIC MATERIAL

IPC classification:
C12P 19/34
Applicant:
Bio-rad Laboratories, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP16164318

PHARMACEUTICAL COMPOSITIONS FOR TREATING HEADACHE AND ELIMINATING NAUSEA

IPC classification:
A61K 31/403, A61K 31/4045, A61K 31/4192, A61K 31/4196, A61K 31/422, A61K 31/454, A61K 31/497, A61K 31/5415, A61P 1/08, A61P 25/06
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
EXAMINATION REQUESTED
EP12166300

Inhibitors of bruton's tyrosine kinase

IPC classification:
A01N 43/90, A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Pharmacyclics Inc
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP11196228

MUCINOUS GLYCOPROTEIN (MUC-1) VACCINE FOR THE TREATMENT OF PROSTATE CANCER

IPC classification:
A61K 9/127, A61K 38/17, A61K 39/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16184263

ANDROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 31/4439, A61K 31/5025, A61P 5/26, A61P 5/28, A61P 35/00, C07D 401/04, C07D 471/04, C07D 487/04
Agent:
William Gwyn Cole, Avidity IP Ltd
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16190185

BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS

IPC classification:
C07K 5/12
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
APPLICATION PUBLISHED
EP15839279

PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/4025, A61K 31/404, A61K 31/4045, A61K 31/415, A61K 31/5415, A61K 47/32, A61K 47/38, A61P 25/06
Agent:
William Gwyn Cole, Avidity IP Ltd
Status:
Request for examination was made

Please Sign in to use this feature